{"id":52196,"date":"2022-06-22T14:26:59","date_gmt":"2022-06-22T18:26:59","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=52196"},"modified":"2024-09-18T16:22:00","modified_gmt":"2024-09-18T20:22:00","slug":"dupixent-alternatives","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/dupixent-alternatives\/","title":{"rendered":"Dupixent alternatives: What can I take instead of Dupixent for atopic dermatitis?"},"content":{"rendered":"

Compare Dupixent alternatives<\/a> | Adbry<\/a> | Cibinqo<\/a> | Eucrisa<\/a> | Opzelura<\/a> | Rinvoq<\/a> | Natural alternatives<\/a> | How to switch meds<\/a><\/span><\/p>\n

Eczema is a condition of inflamed skin that causes symptoms such as itching, dry skin, rashes, scaly patches, blisters, and skin infections. There are several different types of eczema. Atopic dermatitis (AD) is the most common type of <\/span>eczema<\/span><\/a>.\u00a0<\/span><\/p>\n

AD is caused by an overactive immune system, which causes the skin to become very dry and itchy. AD affects <\/span>many<\/span><\/a>\u2014over 9 million children and 16 million adults in the US have AD. About one-third of children and 40% of adults have moderate to severe AD, which can have a big impact on quality of life.\u00a0\u00a0<\/span><\/p>\n

Dupixent<\/span><\/a> is a prescription drug used to treat atopic dermatitis. It is approved by the U.S. Food and Drug Administration (FDA). Dupixent can be used to treat adults and children 6 years and older with moderate to severe AD. Dupixent is administered by injection under the skin (subcutaneous injection). It is generally used when topical therapies (creams, ointments, etc) are not effective or cannot be tolerated. Dupixent can be used in combination with topical corticosteroids.<\/span><\/p>\n

Besides AD, Dupixent has other indications for use. Dupixent can treat moderate to severe asthma. For this indication, Dupixent is used in combination with other medications and can treat adults and children ages 6 years and older who have moderate to severe eosinophilic asthma or asthma that requires oral steroids. Dupixent does not treat acute exacerbations of asthma.\u00a0<\/span><\/p>\n

Another indication for Dupixent use is adults with chronic <\/span>rhinosinusitis<\/span><\/a> (inflammation of the sinus and nasal cavities) with nasal polyps. Dupixent can be used with other medications, when the condition is not adequately controlled.<\/span><\/p>\n

Dupixent is available as a subcutaneous (SQ) injection, which means that it is injected under the skin. For atopic dermatitis, after an initial dose of 600 mg SQ, Dupixent is then given as a 300 mg dose every two weeks. Dupixent is a brand-name medication made by Sanofi-Aventis. There is no generic available for Dupixent at this time.\u00a0<\/span><\/p>\n

Dupixent contains the ingredient dupilumab. Dupixent is a <\/span>biologic<\/span><\/a> and is part of a drug class called <\/span>interleukin-4 receptor alpha antagonists<\/span>. It is also known as a <\/span>monoclonal antibody<\/span><\/a>. Dupixent works by stopping the action of substances in the body that cause symptoms of AD.\u00a0<\/span><\/p>\n

In some cases, <\/span>patients may be looking for an alternative treatment to Dupixent. <\/span>S<\/span>ome people may not have the desired effect and want to try a different medication to see if it works better. Others may have side effects that persist or are bothersome. <\/span>Common side effects of Dupixent<\/span><\/a> (when used for atopic dermatitis) as seen in clinical trials are:<\/span><\/p>\n